Investigation of a novel a cardiovascular inflammation marker, Pentraxin 3

点击翻译按钮获取中文摘要

In Japan as well as industry countries, the mortality caused by cardiovascular disease is worst. General practitioners are expected to make a diagnosis of such disease although they are not cardiologist. ECG or UCG are useful tools to make a diagnosis for such disease, but still, they require specific technique to make a diagnosis. We established a novel cardiovascular marker, Pentraxin 3 (PTX3). Only 0.1mL blood sample reflect the status of the inflammation of vascular. In this study, we have reported that PTX3 was a useful marker to predict the prognosis for patients with acute coronary syndrome, or sleep apnea syndrome.